THE REQUIRED DOSE OF ERYTHROPOIETIN (EPO) DURING RENAL ANEMIA TREATMENT IS RELATED TO THE DEGREE OF IMPAIRMENT IN ERYTHROCYTE DEFORMABILITY

Authors
LINDE T SANDHAGEN B WIKSTROM B DANIELSON BG
Citation
T. Linde et al., THE REQUIRED DOSE OF ERYTHROPOIETIN (EPO) DURING RENAL ANEMIA TREATMENT IS RELATED TO THE DEGREE OF IMPAIRMENT IN ERYTHROCYTE DEFORMABILITY, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1205-1205
Citations number
NO
Categorie Soggetti
Urology & Nephrology
Journal title
Journal of the American Society of Nephrology → ACNP
ISSN journal
10466673
Volume
7
Issue
9
Year of publication
1996
Pages
1205 - 1205
Database
ISI
SICI code
1046-6673(1996)7:9<1205:TRDOE(>2.0.ZU;2-4